Older people who had a COVID-19 infection show a considerably higher risk—as much as 50% to 80% higher than a control group—of developing Alzheimer’s disease within a year. This is according to a new research study of more than 6 million patients aged 65 and older. Researchers report that people
According to a large, new study, older people who were infected with COVID-19 show a substantially higher risk of developing Alzheimer’s disease within a year.infection show a considerably higher risk—as much as 50% to 80% higher than a control group—of developingdisease within a year. This is according to a new research study of more than 6 million patients aged 65 and older.
“The factors that play into the development of Alzheimer’s disease have been poorly understood, but two pieces considered important are prior infections, especially viral infections, and inflammation,” said Pamela Davis, the study’s coauthor. She is a Distinguished University Professor and The Arline H. and Curtis F. Garvin Research Professor at the Case Western Reserve School of Medicine.
For the study, the research team analyzed the anonymous electronic health records of 6.2 million adults 65 and older in the United States with no prior diagnosis of Alzheimer’s disease who received medical treatment between February 2020 and May 2021.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Senior Covid survivors could be 80% more likely to develop Alzheimer’s: StudySenior Covid survivors could be 80% more likely to develop Alzheimer's: Study
Weiterlesen »
People 12 and older can get updated COVID-19 booster shots in Austin areaAustin Public Health, pharmacies and other health care providers in Central Texas are now administering the latest COVID-19 booster shot to eligible groups. | _laterrazas
Weiterlesen »
PolitiFact - Ask PolitiFact: Why were the recent COVID-19 boosters authorized before human trials were completed?Vaccination experts said the updated booster was developed before data could be gathered from human trials so it could be made and distributed as soon as possible.
Weiterlesen »
WSJ News Exclusive | Johns Hopkins Slows Frequency of Covid-19 Data PublicationJohns Hopkins University is scaling back its comprehensive efforts to track the course of the Covid-19 pandemic. The university will cease reporting testing numbers on its data dashboard.
Weiterlesen »
Bioterror concerns 'renewed' amid COVID, but no 'mortal blow' says expert'Major outbreaks of disease foment unrest, in some cases riots, and potentially acts of terrorism.'
Weiterlesen »